Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allarity Therapeutics Inc

0.8215
-0.0621-7.03%
Post-market: 0.8201-0.0014-0.17%19:58 EDT
Volume:1.11M
Turnover:904.22K
Market Cap:13.98M
PE:-0.02
High:0.8676
Open:0.8180
Low:0.7600
Close:0.8836
Loading ...
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 27, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 20, 2021

Major Issues Report

8-K - Current report
Dec 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 15, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 10, 2021

Major Issues Report

8-K - Current report
Dec 06, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 23, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 18, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 12, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 12, 2021

Correspondence

CORRESP [Cover] - Correspondence